Fairvalue-Calculator Fairvalue-Calculator
EN DE

Guangzhou Kingmed Diagnostics Group (603882) Fair Value & Analysis

Healthcare · CN · Market cap 11.4B CNY

Price¥24.62
Fair Value¥23.73
Upside-3.6%
Quality93/100
Evidence: High Range ¥18.77 – ¥28.69

Analysis

Guangzhou Kingmed Diagnostics Group (603882) currently trades at ¥24.62, while our model-based Fair Value estimate is ¥23.73 — implying the stock looks roughly 3.6% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -30% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -53% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -50%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.